Clinical Notes: Rat Data Suggest Eye Risk for CF Drug
(MedPage Today) — Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park.
Clinical Notes: Rat Data Suggest Eye Risk for CF Drug
(MedPage Today) — Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park.
Clinical Notes: Rat Data Suggest Eye Risk for CF Drug
(MedPage Today) — Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park.
Clinical Notes: Rat Data Suggest Eye Risk for CF Drug
(MedPage Today) — Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park.
Clinical Notes: Rat Data Suggest Eye Risk for CF Drug
(MedPage Today) — Cataracts developed in young rats treated with the cystic fibrosis drug ivacaftor (Kalydeco), prompting the FDA to order a label change. Also this week: a fatal viral infection stalks Yosemite Park.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com